UNIVERSITY COMPOUNDING PHARMACY (UCP)
Acquired by
FAGRON
UNIVERSITY COMPOUNDING PHARMACY (UCP) acquired by FAGRON
Target
UNIVERSITY COMPOUNDING PHARMACY (UCP)
Acquirer
FAGRON
Context
Fagron acquired 100% of University Compounding Pharmacy for an Enterprise granting to Fagron a stronghold in California (a high-barrier market) and adds complementary therapeutic expertise (Urology) to its existing US portfolio (which includes Anazao). Fagron expects to realize significant synergies over the next 18-24 months by integrating UCP into its national platform.
The transaction values UNIVERSITY COMPOUNDING PHARMACY (UCP) at an EV/Revenue multiple of LOGIN.
This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Based in San Diego, UCP is a specialized 503A compounding pharmacy. Unlike 503B facilities (which manufacture in bulk for hospitals), 503A pharmacies prepare patient-specific medications prescribed by doctors. UCP has built a strong niche in the "Health & Wellness" segment, with specific leadership in Urology (e.g., erectile dysfunction treatments) and Hormone Replacement Therapy (HRT). It operates in California, a state with notoriously strict pharmacy regulations, making its license and clean compliance record a valuable asset. The company generates annual revenues of around $25 million.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with UNIVERSITY COMPOUNDING PHARMACY (UCP)
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.